Vector Science and Therapeutics Unveils Investigational Microneedle Platform

The company introduced a dissolving peptide-matrix microneedle platform for targeted transdermal delivery, initially aimed at sports and regenerative medicine. The technology is not FDA-approved, and its safety and efficacy are unproven.